305 related articles for article (PubMed ID: 32415340)
21. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
Strassburg CP; Strassburg A; Nguyen N; Li Q; Manns MP; Tukey RH
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):489-98. PubMed ID: 10024527
[TBL] [Abstract][Full Text] [Related]
22. Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes.
Chen A; Zhou X; Cheng Y; Tang S; Liu M; Wang X
Toxicol Lett; 2018 Oct; 295():379-389. PubMed ID: 30036684
[TBL] [Abstract][Full Text] [Related]
23. Optimization of Experimental Conditions of Automated Glucuronidation Assays in Human Liver Microsomes Using a Cocktail Approach and Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.
Badée J; Qiu N; Parrott N; Collier AC; Schmidt S; Fowler S
Drug Metab Dispos; 2019 Feb; 47(2):124-134. PubMed ID: 30478159
[TBL] [Abstract][Full Text] [Related]
24. Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9.
Iyer LV; Ho MN; Shinn WM; Bradford WW; Tanga MJ; Nath SS; Green CE
Toxicol Sci; 2003 May; 73(1):36-43. PubMed ID: 12657745
[TBL] [Abstract][Full Text] [Related]
25. Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms.
Sakaguchi K; Green M; Stock N; Reger TS; Zunic J; King C
Arch Biochem Biophys; 2004 Apr; 424(2):219-25. PubMed ID: 15047194
[TBL] [Abstract][Full Text] [Related]
26. UDP-glucuronosyltransferase 2B15 (UGT2B15) is the major enzyme responsible for sipoglitazar glucuronidation in humans: retrospective identification of the UGT isoform by in vitro analysis and the effect of UGT2B15*2 mutation.
Nishihara M; Hiura Y; Kawaguchi N; Takahashi J; Asahi S
Drug Metab Pharmacokinet; 2013; 28(6):475-84. PubMed ID: 23648677
[TBL] [Abstract][Full Text] [Related]
27. A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders.
Fang ZZ; He RR; Cao YF; Tanaka N; Jiang C; Krausz KW; Qi Y; Dong PP; Ai CZ; Sun XY; Hong M; Ge GB; Gonzalez FJ; Ma XC; Sun HZ
J Lipid Res; 2013 Dec; 54(12):3334-44. PubMed ID: 24115227
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Hepatic UDP-Glucuronosyltransferase Enzyme Abundance-Activity Correlations and Population Variability Using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes.
Takahashi RH; Forrest WF; Smith AD; Badee J; Qiu N; Schmidt S; Collier AC; Parrott N; Fowler S
Drug Metab Dispos; 2021 Sep; 49(9):760-769. PubMed ID: 34187837
[TBL] [Abstract][Full Text] [Related]
29. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
Rouguieg K; Picard N; Sauvage FL; Gaulier JM; Marquet P
Drug Metab Dispos; 2010 Jan; 38(1):40-5. PubMed ID: 19841060
[TBL] [Abstract][Full Text] [Related]
30. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.
Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T
Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132
[TBL] [Abstract][Full Text] [Related]
31. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
[TBL] [Abstract][Full Text] [Related]
32. Human variability in polymorphic CYP2D6 metabolism: Implications for the risk assessment of chemicals in food and emerging designer drugs.
Darney K; Lautz LS; Béchaux C; Wiecek W; Testai E; Amzal B; Dorne JLCM
Environ Int; 2021 Nov; 156():106760. PubMed ID: 34256299
[TBL] [Abstract][Full Text] [Related]
33. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
Hanioka N; Naito T; Narimatsu S
Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
[TBL] [Abstract][Full Text] [Related]
34. Development of an assay using 4-trifluoromethylumbelliferyl as a marker substrate for assessment of drug-drug interactions to multiple isoforms of UDP-glucuronosyltransferases.
Baranczewski P; Kallin A; Andersson A; Hagigi S; Aberg M; Postlind H; Mankowitz L
Assay Drug Dev Technol; 2004 Aug; 2(4):345-52. PubMed ID: 15357915
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of fifteen phthalate esters in human cDNA-expressed UDP-glucuronosyltransferase supersomes.
Cao YF; Du Z; Zhu ZT; Sun HZ; Fu ZW; Yang K; Liu YZ; Hu CM; Dong PP; Gonzalez FJ; Fang ZZ
Chemosphere; 2017 Oct; 185():983-990. PubMed ID: 28753904
[TBL] [Abstract][Full Text] [Related]
36. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
Watanabe Y; Nakajima M; Yokoi T
Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
[TBL] [Abstract][Full Text] [Related]
37. Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactions.
Nakajima M; Yamanaka H; Fujiwara R; Katoh M; Yokoi T
Drug Metab Dispos; 2007 Sep; 35(9):1679-86. PubMed ID: 17576806
[TBL] [Abstract][Full Text] [Related]
38. Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment.
Quignot N; Więcek W; Lautz L; Dorne JL; Amzal B
Toxicol Lett; 2021 Feb; 337():111-120. PubMed ID: 33232775
[TBL] [Abstract][Full Text] [Related]
39. Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
Lu L; Zhou J; Shi J; Peng XJ; Qi XX; Wang Y; Li FY; Zhou FY; Liu L; Liu ZQ
PLoS One; 2015; 10(5):e0127524. PubMed ID: 26010150
[TBL] [Abstract][Full Text] [Related]
40. Per- and polyfluoroalkyl substances display structure-dependent inhibition towards UDP-glucuronosyltransferases.
Liu YZ; Zhang ZP; Fu ZW; Yang K; Ding N; Hu LG; Fang ZZ; Zhuo X
Environ Pollut; 2019 Nov; 254(Pt B):113093. PubMed ID: 31472452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
